The following is a glossary of a number of the terms and acronyms which can be found within this document:
ABC
Anti-Bribery and Anti-Corruption
AER
Actual Exchange Rate
ANZ
Australia and New Zealand
API
Active Pharmaceutical Ingredient
APM
Alternative Performance Measures
AVA
Association of Veterinary Anaesthetists
BBSRC
Biotechnology and Biological Sciences Research Council
BEPS
Base Erosion Profit Shifting
Bioequivalence
The demonstration that the proposed formulation has the same biological effects as the pioneer product to which it is being compared. This is usually demonstrated by comparing blood concentrations of the active over time, but can be compared using a clinical endpoint (e.g. lowering of a worm count) for drugs that are not absorbed or for which blood levels cannot be determined
bps
Basis Points
CAGR
Compound Annual Growth Rate
CAP
Companion Animal Products
Capex
Capital Expenditure
CDGP
Canine Diabetes Genetics Partnership
CER
Constant Exchange Rate
CMO
Contract Manufacturing Organisation
Code
UK Corporate Governance Code 2016
CRM
Client Relationship Management
CRO
Contract Research Organisation
CSOP
Company Share Option Plan
CSR
Corporate Social Responsibility
Dechra Values or Values
Dedication, Enjoyment, Courage, Honesty, Relationships and Ambition
DPM
Dechra Pharmaceuticals Manufacturing
DSC
Dechra Service Center
DVP
Dechra Veterinary Products
DVP EU
Dechra Veterinary Products EU or Dechra Veterinary Products Europe
DVP International
Dechra Veterinary Products International
DVP NA
Dechra Veterinary Products North America
DVP US
Dechra Veterinary Products US
EBIT
Earnings before interest and tax. This is the same as operating profit
EBITDA
Earnings before interest, tax, depreciation and amortisation
EBVS
European Board of Veterinary Specialists
EPS
Earnings Per Share
ERP
Enterprise Resource Planning
ESPP
Employee Stock Purchase Plan
ETR
Effective Tax Rate
EU Pharmaceuticals
European Pharmaceuticals Segment comprising DVP EU, DVP International and DPM
Executive Directors
The Executive Directors of the Company, currently Ian Page and Tony Griffin
FAP
Food producing Animal Products
FDA
US Food and Drug Administration; a federal agency of the US Department of Health and Human Services
FRC
Financial Reporting Council
FRS
Financial Reporting Standards
FTSE
Companies listed on the London Stock Exchange
FTSE 250/350 Index
An index comprising the 101st to 350th largest companies listed on the London Stock Exchange in terms of their market capitalisation
GAAP
Generally Accepted Accounting Practices
GDPR
General Data Protection Regulation
GHG
Greenhouse Gas
GRT
Gross Registered Tonnage
GPTW
Great Place To Work
HR
Human Resources
IAS
International Accounting Standards
IFRSs
International Financial Reporting Standards
IT
Information Technology
KPI
Key Performance Indicator
LATAM
Latin America
Leverage
The ratio of Net Debt to underlying EBITDA
LIBOR
The London Inter-Bank Offered Rate
LTA
Lost Time Accident
LTAFR
Lost Time Accident Frequency Rate
LTIP
Long Term Incentive Plan
M&A
Mergers and Acquisitions
MAT
Moving Annual Total
Non-Executive Directors
The Non-Executive Directors of the Company, currently Tony Rice, Lisa Bright, Julian Heslop, Lawson Macartney and Ishbel Macpherson
NA Pharmaceuticals
North American Pharmaceuticals Segment comprising DVP US, Canada and Dechra-Brovel
New Code
UK Corporate Governance Code 2018
OECD
The Organisation for Economic Cooperation and Development
Ordinary Shares
An ordinary share of 1 pence in the share capital of the Company
Oracle Programme
Enterprise Resources Planning (ERP) software
PDRA
Dechra’s Product Development and Regulatory Affairs team
PEA
Palmitoylethanolamide
POMs
Prescription Only Medicines
PTSD
Post-Traumatic Stress Disorders
Qualifying LTIP Award
Qualifying LTIP Awards comprises a CSOP option and an ordinary nilcost LTIP award, with the ordinary award scaled back at exercise to take account of any gain made on exercise of the CSOP option
R&D
Research and Development
RCF
Revolving Credit Facility
RIDDOR
Reporting of Injuries, Diseases and Dangerous Occurrences Regulations
Rights Issue
The three for ten rights issue of 20,040,653 shares, details of which are set out in the prospectus of the Company dated 25 April 2012
ROCE
Return On Capital Employed
RPI
Retail Price Index
RCVS
Royal College of Veterinary Surgeons
SAYE
Save As You Earn Share Scheme
SET
Senior Executive Team
SG&A
Selling, General and Administrative Expenses
S&OP
Sales & Operations Planning
TSR
Total Shareholder Return